Gravity Analytica

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

LNSR 10.31.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-11-07

Name of Upcoming Event:LENSAR Q3 2024 Financial Results Conference Call

Full Press Release SEC Filings Our LNSR Tweets

About Gravity Analytica

Recent Filings

ORLANDO, Fla.,Oct. 31, 2024(GLOBE NEWSWIRE) --LENSAR, Inc.(Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2024 financial results will be released before market open onThursday, November 7, 2024. LENSAR’s management will host a conference call and webcast at8:30 am ETonThursday, November 7, 2024to discuss the financial results and recent corporate highlights.

To participate by telephone, please dial (800) 715-9871 (Domestic) or (646) 307 1963 (International). The conference ID is 8444582. To access the live webcast, please go to the Investors section of LENSAR’s website atwww.lensar.com. Following the live webcast, an archived version of the call will be available on the website.

AboutLENSARLENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY Robotic Cataract Laser SystemTM as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reducing overhead. ALLY includes LENSAR’s proprietary Streamline^®software technology, which is designed to guide surgeons to achieve better outcomes.

Contacts:		Lee Roth/Cameron Radinovic
Thomas R. Staab, II, CFO		Burns McClellanforLENSAR
ir.contact@lensar.com		lroth@burnsmc.com/cradinovic@burnsmc.com

Source: LENSAR, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com